Trial in Progress – Alliance A051901 – Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma (PCNSL)
- Citation:
- Blood vol 144 (Supplement 1) 4502.4
- Meeting Instance:
- ASH 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Alvaro J. Alencar Olivia Bobek Neha Mehta-Shah Narendranath Epperla Christine Lu-Emerson Sarah Rutherford Adam Olszewski Thomas Ollila Samuel Singer Travis J. Dockter Susan Geyer Lori J. Rosenstein Macarena De La Fuente Eric Hsi Shira Dinner James Rubenstein Nancy Bartlett John P. Leonard
- Networks:
- CA824, FL028, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-UT003, MAINE, NY018, RI005, WINCORP
- Study
- Alliance-A051901
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: